Mainz Biomed BV

Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. Its offerings include ColoAlert, a molecular genetic stool test for colorectal cancer, and PancAlert, a stool-based screening test under development for pancreatic cancer. The company also operates a clinical diagnostic laboratory and distributes its IVD kits to third-party laboratories. It has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of a colorectal cancer screening product. Founded in 2008, Mainz Biomed N.V. is based in Mainz, Germany.